𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A rational approach to androgen therapy for hypogonadal men with prostate cancer

✍ Scribed by Kaufman, J

Book ID
110043501
Publisher
Nature Publishing Group
Year
2005
Tongue
English
Weight
82 KB
Volume
18
Category
Article
ISSN
0955-9930

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Does androgen-deprivation therapy accele
Does androgen-deprivation therapy accelerate the development of frailty in older men with prostate cancer? : A conceptual review
✍ Kathryn Bylow; Supriya G. Mohile; Walter M. Stadler; William Dale πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 143 KB πŸ‘ 1 views

## Abstract The majority of men with prostate cancer are aged β‰₯65 years. Men, as they age, are more likely to suffer from impaired physical function. The standard treatment for recurrent prostate cancer is androgen‐deprivation therapy (ADT). Well‐established toxicities from ADT include lean weight

Osteoporosis in men with prostate carcin
Osteoporosis in men with prostate carcinoma receiving androgen-deprivation therapy : Recommendations for diagnosis and therapies
✍ Terrence H. Diamond; Celestia S. Higano; Matthew R. Smith; Theresa A. Guise; Fre πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 105 KB πŸ‘ 2 views

## Abstract ## BACKGROUND Androgen‐deprivation therapy (ADT) is prescribed with increasing frequency for men with prostate carcinoma. There is growing concern about the effects of such therapy on the skeleton. In the current review, the authors addressed the current research, diagnostic methods, a